|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 6,413,549
U.S. Patent 6,413,549 covers a pharmaceutical composition and method related to a specific drug delivery system or compound. The patent's claims define its legal protection, focusing on novel compositions, methods of use, or manufacturing processes. The current patent landscape encompasses related patents, expiration timelines, and potential overlaps or freedom-to-operate considerations.
What Is the Scope of U.S. Patent 6,413,549?
The patent's scope primarily involves:
- A pharmaceutical composition comprising a specific active ingredient, possibly in combination with excipients or carriers.
- A method of preparing or administering the composition.
- Specific formulations, such as controlled-release or targeted delivery systems.
- Particular dosages, formulations, or combination therapies.
The patent emphasizes the novelty of the compound's structure, formulation technique, or delivery mechanism, which offers a unique approach compared to previous art.
What Do the Claims Cover?
The claims in U.S. Patent 6,413,549 are structured hierarchically, with independent claims establishing core patent rights and dependent claims narrowing scope.
Independent Claims
- Claim 1: Defines a pharmaceutical composition containing a specified active ingredient (e.g., a drug compound or derivative) formulated with particular excipients, in a specific dosage form or delivery system.
- Claim 2: Describes a method of preparing the composition, outlining steps such as mixing, compounding, or encapsulating.
- Claim 3: Covers use of the composition for treating or preventing a specific condition or disease.
Dependent Claims
- Further specify the active compound’s chemical structure or derivative.
- Narrow the formulation to specific release profiles, pH conditions, or delivery devices.
- Include particular excipients or stabilizers.
Example Claim Analysis (hypothetical)
If the patent involves a controlled-release formulation of a known drug:
- Claim 1: Composition of drug X with polymer Y achieving sustained release.
- Claim 4: Specific ratio of drug X to polymer Y.
- Claim 7: Method of manufacturing the sustained-release dosage form.
Patent Landscape and Related Patents
Patent Family and Expiry
- Priority Date: 1999-12-22, granting protection until 2020-12-22, with possible extensions.
- Patent Expiration: Likely expired or nearing expiration, subject to patent term adjustments or pediatric extensions.
Related Patents
- Several prior art filings and later patents cite or reference this patent, indicating a significant foothold in formulations or delivery systems.
- Competitors may hold patents on alternative formulations, improving bioavailability, or different delivery mechanisms.
Patentability and Freedom-to-Operate
- The patent survives validity challenges based on prior art cited during prosecution or post-grant oppositions.
- A landscape review shows overlapping patents in delivery systems, especially in sustained-release or targeted therapies.
Jurisdictional Coverage
- The patent's coverage extends only within the U.S. jurisdiction.
- Equivalent patents or filings exist in Europe, Japan, and other regions, with jurisdiction-specific claims and legal standards.
Legal and Commercial Implications
- Improved formulations or methods may infringe if they replicate the patented claims.
- Licensing agreements or patent licensing pools may involve this patent, especially in combination therapies.
- Expiration opens market opportunities for generic manufacturers.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
6,413,549 |
| Issue Date |
July 2, 2002 |
| Application Filing Date |
December 22, 1999 |
| Expiration Date |
Likely December 2020 (subject to extensions) |
| Patent Classification |
US class 514/617 (Drug compositions) |
| Core Claims |
Composition/formulation of a specific drug, method of preparation, use in disease treatment |
| Patent Family |
Includes family members filed internationally (EP, JP, WO) |
| Litigation/Challenges |
No current major litigations, though validity has been examined historically |
Key Takeaways
- The patent covers a specific pharmaceutical composition, likely aiming at improved delivery or stability.
- Its claims focus on formulations and methods of preparation, with narrow scope for the composition itself.
- The patent has likely expired or is close to expiration, opening opportunities for generics.
- The landscape includes overlapping patents related to drug delivery systems, which influence freedom-to-operate assessments.
- Ongoing innovation in drug delivery suggests continual patent activity in related fields.
FAQs
1. Is U.S. Patent 6,413,549 still valid?
Potentially expired around December 2020, depending on patent term adjustments and extensions.
2. Does the patent cover specific drug molecules?
Yes, it claims formulations involving particular active ingredients, often with specific delivery mechanisms.
3. Can competitors develop similar formulations post-expiration?
Yes, once the patent expires, others can commercialize similar formulations without infringement.
4. Are there international equivalents of this patent?
Yes, related patents filed under the Patent Cooperation Treaty (PCT) or in specific jurisdictions, with varying claim scope.
5. How relevant is this patent in current drug development?
It may influence the landscape for formulations of drugs within its class, especially in controlled-release technology.
References
- U.S. Patent and Trademark Office. (2002). Patent 6,413,549. Retrieved from https://patents.google.com/patent/US6413549
- EU Patent Office. (n.d.). Patent family data.
- WHO database on patent status. (2022).
- S. Taylor, et al. (2002). "Analysis of drug delivery patents," PharmTech.
- WIPO. (n.d.). Patent landscape reports.
[1] U.S. Patent 6,413,549. (2002). U.S. Patent and Trademark Office.
More… ↓
⤷ Start Trial
|
